Guja, Cristian Frías, Juan P. Suchower, Lisa Hardy, Elise Marr, Galina Sjöström, C. David Jabbour, Serge A. Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease <p>The above Summary Slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).<br></p> <p>© The authors, CC-BY-NC 2020.<b> </b></p> Chronic;CKD2;CKD3;Exenatide;Glucagon-like peptide 1;Pooled analysis;Renal insufficiency;Safety;Type 2 diabetes mellitus 2020-04-14
    https://adisjournals.figshare.com/articles/figure/Safety_and_Efficacy_of_Exenatide_Once_Weekly_in_Participants_with_Type_2_Diabetes_and_Stage_2_3_Chronic_Kidney_Disease/12059103
10.6084/m9.figshare.12059103.v1